BSE Live
Nov 28, 16:01Prev. Close
721.75
Open Price
723.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 28, 15:45Prev. Close
719.35
Open Price
719.00
Bid Price (Qty.)
691.15 (1224)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Venus Remedies (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 48.95 | 49.26 | 46.04 | 33.41 | 18.41 | |
| Net CashFlow From Operating Activities | 35.25 | 19.41 | 21.23 | 26.93 | 8.90 | |
| Net Cash Used In Investing Activities | -52.35 | -55.03 | -33.78 | -87.99 | -24.93 | |
| Net Cash Used From Financing Activities | 17.81 | 35.87 | 10.69 | 63.42 | 15.23 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.71 | 0.24 | -1.86 | 2.36 | -0.80 | |
| Cash And Cash Equivalents Begin of Year | 1.29 | 1.05 | 2.92 | 0.56 | 1.36 | |
| Cash And Cash Equivalents End Of Year | 2.00 | 1.29 | 1.05 | 2.92 | 0.56 |
17.11.2025
Venus Remedies Consolidated September 2025 Net Sales at Rs 192.75 crore, up 15.11% Y-o-Y
12.11.2025
Venus Remedies Standalone September 2025 Net Sales at Rs 192.65 crore, up 15.35% Y-o-Y
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
17.11.2025
Venus Remedies Consolidated September 2025 Net Sales at Rs 192.75 crore, up 15.11% Y-o-Y
12.11.2025
Venus Remedies Standalone September 2025 Net Sales at Rs 192.65 crore, up 15.35% Y-o-Y
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y